This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Maria A. Saornil, MD; Marian R. Fisher, PhD; R. Jean Campbell, MD; Dennis M. Robertson, MD; John D. Earle, MD; Ralph C. Eagle, Jr, MD; Jerry A. Shields, MD; Carol L. Shields, MD; Suresh R. Chandra, MD; Daniel M. Albert, MD

Arch Ophthalmol. 1997;115(11):1395-1400.

Abstract
Objectives
To describe the histopathologic findings attributable to irradiation in eyes with uveal malignant melanoma treated with iodine I 125 brachytherapy and to compare these findings with those reviewed in a previous study that compared histopathologic findings in eyes enucleated after proton beam teletherapy with those seen in eyes in a nonirradiated control group.

Methods
The slides from 22 eyes with uveal melanoma that had undergone enucleation after the administration of ¹²⁵I brachytherapy were studied. The histopathologic features of the tumor and the retina were graded. Results were compared with findings from a previously reported group of 47 proton beam-treated eyes and its control group.

Results
Patient age, time between irradiation and enucleation, and ciliary body involvement were similar for the ¹²⁵I brachytherapy-treated group and the proton beamtreated group and its control group. This allows comparison of the histopathologic findings. Comparing the ¹²⁵I brachytherapy- and proton beam-treated groups, most histopathologic features were similar with nominally statistically significant differences only for cell type, number of mitotic figures, and fibrous metaplasia of the retinal pigment epithelium adjacent to the tumor.

Conclusions
Irradiation of uveal melanoma induces changes in the tumor and in the surrounding retina. Brachytherapy and charged particle therapy are the 2 principal methods of irradiation. This study demonstrates that similar changes are produced by ¹²⁵I plaque irradiation and proton beam irradiation.

Author Affiliations
From the Department of Ophthalmology, Instituto de Oftalmobiologia Aplicada Universidad de Valladolid, Valladolid, Spain (Dr Saornil); the Departments of Biostatistics (Dr Fisher) and Ophthalmology and Visual Sciences (Drs Saornil, Chandra, and Albert), University of Wisconsin Medical School, Madison; Departments of Laboratory Medicine and Pathology (Dr Campbell), Ophthalmology (Dr Robertson), and Radiotherapy (Dr Earle), Mayo Clinic, Mayo Foundation, Rochester, Minn; and Department of Ophthalmology, Wills Eye Hospital, Philadelphia, Pa (Drs Eagle, J. A. Shields, and C. L. Shields).; Dr Earle is now with the Department of Radiation Oncology, University of California, Davis, Cancer Center, Sacramento.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study
Pe'er et al.
Br J Ophthalmol 2001;85:1208-1212.
ABSTRACT | FULL TEXT  

External Beam Irradiation of Subfoveal Choroidal Neovascularization Complicating Age-Related Macular Degeneration: One-Year Results of a Prospective, Double-Masked, Randomized Clinical Trial
Marcus et al.
Arch Ophthalmol 2001;119:171-180.
ABSTRACT | FULL TEXT  

Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas
Chiquet et al.
Br J Ophthalmol 2000;84:98-102.
ABSTRACT | FULL TEXT